Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
12-24 hours) treatment results in a progressive appearance of cleaved caspases-3
thus does not possess mGlu5 NAM activity
22(20):4084-101
9S)-2-[(2S
1-10H3/b13-11-
AHAS inhibitor Size:Solid 10 mg 12-24 hours) treatment results inBTB06584 is an IF1 dependent selective inhibitor of the mitochondrial F1 Fo ATPase. BTB06584 inhibited F1 Fo ATPase activity with no effect on m or O2 consumption. BTB06584 efficiency was increased by IF1 overexpression and reduced by silencing the protein. BTB06584 may represent a valuable tool to selectively inhibit mitochondrial F1 Fo ATPase activity without compromising ATP synthesis and to limit ischaemia induced injury caused by reversal of the
US$ 17.95
US$ 16.95
US$ 24.95
US$ 35.95
US$ 239.50
US$ 45.95
US$ 25.95